Clinical Trial

Post-Concussion Musculoskeletal Injury Risks

Recruiting
View on ClinicalTrials.gov →
Summary
Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more than 350,000 in the past 19 years and account for 22% of all combat casualties. Concussion, a mild form of TBI, increases MSKI risk in physically active individuals, including Service Members. The overall goal of the study is to identify the neuromuscular control mechanisms that increase MSKI risk following concussion. It is hypothesized that concussed individuals will display abnormal neuromuscular function that increases MSKI risk, as compared to non-concussed controls. The study will employ a multi-center, prospective, case-matched control observational study to identify the differences in neuromuscular function following concussion that may contribute to increased MSKI risk. Once the neuromuscular control mechanisms that increase MSKI risk following concussion are identified, targeted risk mitigation strategies can be developed to reduce MSKI risk.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-11-09; most recent amendment 2026-01-23.
Status change: Not Yet Recruiting → Recruiting 2022-11-28
Trial Details
NCT Number NCT05122728
Lead Sponsor Walter Reed National Military Medical Center
Collaborators: Womack Army Medical Center, University of Georgia
Conditions Musculoskeletal Injury
Enrollment 148 participants
Start Date 2022-10-20
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-27